newsfilter
← Latest News
ACCESS Newswire·

NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA

SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company , and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based